Aurobindo Pharma announces tender offer to buyback up to 54.24 lakh shares at ₹1,475 each for ₹800 crore aggregate.
Buyback opens April 23 and closes April 29, 2026, with 15% reservation for small shareholders holding ≤144 shares.
Promoter group intends to participate, tendering up to 54.33 lakh shares; post-buyback holding may increase to 51.88%.
Funding from free reserves; statutory auditors confirm solvency and adequate financial arrangements for the buyback obligations.